Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics
Small-cell lung cancer (SCLC) has a poor prognosis and can be diagnosed with systemic metastases. Nevertheless, the molecular mechanisms underlying the development of SCLC are unclear, requiring further investigation. The current research aims to identify relevant biomarkers and available drugs to t...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2023-10-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2023-0806 |